Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows.
Interesting Highlights From Today's 52-Week Lows
Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
NextCure And The National Cancer Institute Announce Preclinical Data In Journal Of Clinical Investigation
NextCure, Inc. (NASDAQ:NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today
Ladenburg Thalmann Initiates Coverage On NextCure with Buy Rating, Announces Price Target of $16
Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on NextCure (NASDAQ:NXTC) with a Buy rating and announces Price Target of $16.
75 Biggest Movers From Yesterday
Gainers
Society Pass Incorporated (NASDAQ: SOPA) surged 436.7% to settle at $48.30 on Tuesday after the company priced its IPO at $9 per share.
58 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Dover Motorsports, Inc. (NYSE: DVD) shares climbed 60.3% to $3.59 after Speedway Motorsports announced it will acquire the company for $3.61 per share in cash.
Needham Maintains Buy on NextCure, Lowers Price Target to $14
Needham analyst Gil Blum maintains NextCure (NASDAQ:NXTC) with a Buy and lowers the price target from $30 to $14.
NextCure Announces Publication Of Preclinical Data for NC410
NextCure, Inc. (NASDAQ:NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
Here's a roundup of top developments in the biotech space over the last 24 hours.
Click here for accessing Benzinga's FDA Calendar
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 30)